User: Guest  Login
Title:

Can engineered "designer" T cells outsmart chronic hepatitis B?

Document type:
Journal Article
Author(s):
Protzer, U; Abken, H
Abstract:
More than 350 million people worldwide are persistently infected with human heptatitis B virus (HBV) and at risk to develop liver cirrhosis and hepatocellular carcinoma making long-term treatment necessary. While a vaccine is available and new antiviral drugs are being developed, elimination of persistently infected cells is still a major issue. Recent efforts in adoptive cell therapy are experimentally exploring immunotherapeutic elimination of HBV-infected cells by means of a biological attack...     »
Journal title abbreviation:
Hepat Res Treat
Year:
2010
Journal volume:
2010
Pages contribution:
901216
Language:
eng
Fulltext / DOI:
doi:10.1155/2010/901216
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/21188203
Print-ISSN:
2090-1364
TUM Institution:
Institut für Virologie
 BibTeX